Abstract
Experiments on rats trained passive avoidance task showed that N-phenyl-acetyl-L-prolyl-glycyl ethyl ester, peptide analog of piracetam (GVS-111, Noopept) after oral administration retained antiamnesic activity previously observed after its parenteral administration. Effective doses were 0.5-10 mg/kg. Experiments on a specially-developed model of active avoidance (massive one-session learning schedule) showed that GVS-111 stimulated one-session learning after single administration, while after repeated administration it increased the number of successful learners among those animals who failed after initial training. In this respect, GVS-111 principally differs from its main metabolite cycloprolylglycine and standard nootropic piracetam.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
I. P. Ashmarin, Science and Technology Achievements, Human and Animal Physiology [in Russian], Moscow (1988).
S. S. Boiko, R. U. Ostrovskaya, V. P. Zherdev, et al., Byull. Eksp. Biol. Med., 129, No. 4, 426–429 (2000).
D. L. Vysotsky, A. L. Vysotsky, T. A. Gudasheva, et al., Ros. Fisiol. Zhurn., 84, No. 3, 157–163 (1998).
T. A. Gudasheva, R. U. Ostrovskaya, G. A. Romanova, et al., Byull. Eksp. Biol. Med., 128, No. 10, 411–413 (1999).
T. A. Gudasheva, S. S. Trofimov, M. Yu. Kosoi, et al., Khim. Farm. Zh., 11, 18–22 (1985).
A. N. Inosemtsev, S. S. Trofimov, G. G. Borlikova, et al., Eksp. Klin. Farmakol., 61, No. 3, 10–12 (1998).
R. I. Kruglikov, Neurochemical Mechanisms of Learning and Memory, [in Russian] Moscow (1981).
G. Flicker and J. Drewe, J. Pept. Sci., 2, No. 4, 195–211 (1996).
C. Giurgea, Actual Pharmacol. (Paris), 25, 115–156 (1972).
T. A. Gudasheva, T. A. Voronina, R. U. Ostrovskaya, et al., Eur. J. Med. Chem., 31, 157 (1996).
R. U. Ostrovskaya, T. A. Gudasheva, S. S. Trofimov, et al., in: Biological Basis of Individual Sensitivity to Psychotropic Drugs, Edinburg, (1994), 79–91.
R. U. Ostrovskaya, T. A. Gudasheva, S. S. Trofimov, et al., Behav. Pharmacol., 8, 68–69 (1999).
M. Sansone and A. Oliverio, Progr. Neuropsychopharmacol. Biol. Psychiatry, 13, 89–97 (1989).
Z. Speiser and F. G. Galafaro, Neuropharmacology, 28, No. 12, 1325–1332 (1989).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ostrovskaya, R.U., Mirsoev, T.K., Romanova, G.A. et al. Proline-Containing Dipeptide GVS-111 Retains Nootropic Activity after Oral Administration. Bulletin of Experimental Biology and Medicine 132, 959–962 (2001). https://doi.org/10.1023/A:1013663126973
Issue Date:
DOI: https://doi.org/10.1023/A:1013663126973